The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMacfarlane Grp. Regulatory News (MACF)

Share Price Information for Macfarlane Grp. (MACF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 141.00
Bid: 140.00
Ask: 141.50
Change: 0.50 (0.36%)
Spread: 1.50 (1.071%)
Open: 141.00
High: 141.00
Low: 141.00
Prev. Close: 140.50
MACF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Oversubscribed Placing

26 Jul 2016 09:49

RNS Number : 2367F
Macfarlane Group PLC
26 July 2016
 

THIS ANNOUNCEMENT, AND THE INFORMATION CONTAINED HEREIN, IS RESTRICTED AND NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES OF AMERICA, CANADA, THE REPUBLIC OF SOUTH AFRICA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

 

26 July 2016

 

MACFARLANE GROUP PLC

 

 ("Macfarlane" or the "Company")

Result of Oversubscribed Placing

 

Following the earlier announcement this morning that Macfarlane has entered into a conditional agreement to acquire Nelsons and is conditionally raising £5.8 million through a placing of new ordinary shares in the Company, Macfarlane is pleased to announce the completion of an oversubscribed Placing.

 

A total of 10,000,000 Placing Shares have been placed at a Placing Price of 58 pence per Placing Share (the "Placing Price"), representing a discount of approximately 4.1 per cent. to the closing price on 25 July 2016, being the last practicable date before this announcement.

 

Based on the Placing Price, the gross proceeds of the Placing are £5.8 million. The Placing Shares and the Vendor Shares will represent approximately 7.8 per cent. of the enlarged issued ordinary share capital of the Company.

Application will be made to the UKLA and the London Stock Exchange for the Placing Shares and Vendor Shares, a total of 11,724,137 Ordinary Shares, to be admitted to the Official List and to trading on the Main Market.

It is expected that Admission will become effective and that dealings for normal settlement in the Placing Shares and Vendor Shares on the Main Market will commence at 8.00 a.m. on 29 July 2016.

Related party transactions

The Company has today been notified that the following substantial shareholders of the Company have agreed to acquire Placing Shares pursuant to the terms of the Placing at the Placing Price. Following Admission, their beneficial interests will be as follows:

 

Shareholder

No. of Placing Shares acquired pursuant to the terms of the Placing and aggregate value at Placing Price

Resulting holding following Admission

% of enlarged issued voting share capital

Discretionary Unit Fund Managers Limited ("DUFM")

415,517

£240,999.86

21,241,368

15.58

Hargreaves Hale Limited ("Hargreaves")

3,017,241

£1,749,999.78

15,843,241

11.62

 

The Placing is deemed to be a related party transaction as described in the Listing Rules. As the participation of Hargreaves and DUFM in the Placing is less than 5% under the relevant class tests in the Listing Rules, shareholder approval is not required under Listing Rule 11. 

However the transaction falls within Listing Rule 11.1.10R and as such the Company is required to obtain from Arden as Sponsor to the Company confirmation the terms of the proposed transaction or arrangement with the related party are fair and reasonable as far as the shareholders of the Company are concerned.

The Directors, who have consulted with Arden in its capacity as Financial Adviser and Sponsor to the Company, consider the Placing to be fair and reasonable insofar as Shareholders are concerned and to be in the best interests of the Company and its Shareholders as a whole.

All terms in this announcement have the meaning given to them in the announcement made by the Company at 8 a.m. on 26 July 2016 unless otherwise defined herein.

 

Further enquiries:

Macfarlane Group

Tel: 0141 333 9666

Graeme Bissett

Chairman

Peter Atkinson

Chief Executive

John Love

Finance Director

Arden Partners

Tel: 0207 614 5900

Steve Douglas / Ciaran Walsh

Corporate Finance

 

Matt Groves / Catherine Miles

Corporate Broking

 

 

 

Spreng Thomson

Tel: 0141 548 5191

Callum Spreng

Mob: 07803 970103

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEAKADQFBKKAOB
Date   Source Headline
25th Mar 20224:12 pmRNSDirector/PDMR Shareholding
11th Mar 20223:41 pmRNSDirector/PDMR Shareholding
24th Feb 20221:00 pmRNSDividend Payment Date
24th Feb 20227:00 amRNSFinal Results
11th Feb 20227:00 amRNSNotice of Results
4th Jan 20227:00 amRNSDisposal
25th Nov 20217:00 amRNSTrading Update
18th Nov 202110:17 amRNSHolding(s) in Company
26th Aug 20217:00 amRNSHalf-year Report
6th Aug 20217:00 amRNSNotice of Interim Results
25th Jun 20214:41 pmRNSSecond Price Monitoring Extn
25th Jun 20214:36 pmRNSPrice Monitoring Extension
12th May 20217:00 amRNSResult of AGM
11th May 202112:00 pmRNSBoard Changes
11th May 202112:00 pmRNSAGM Statement
13th Apr 20214:41 pmRNSSecond Price Monitoring Extn
13th Apr 20214:35 pmRNSPrice Monitoring Extension
6th Apr 20217:00 amRNSNotice of AGM
6th Apr 20217:00 amRNSAnnual Report 2020
1st Apr 20217:00 amRNSAcquisition
26th Mar 20217:00 amRNSDirector/PDMR Shareholding
4th Mar 20214:41 pmRNSSecond Price Monitoring Extn
4th Mar 20214:35 pmRNSPrice Monitoring Extension
4th Mar 20212:40 pmRNSHolding(s) in Company
1st Mar 20217:00 amRNSAcquisition
25th Feb 20217:00 amRNSFinal Results
16th Feb 20217:00 amRNSNotice of Results
5th Feb 20217:00 amRNSAppointment of Sole Broker
14th Dec 20207:00 amRNSCompany Secretary Change
19th Nov 20207:01 amRNSBoard Changes
19th Nov 20207:00 amRNSTrading Update
5th Oct 20202:38 pmRNSDirector/PDMR Shareholding
15th Sep 202012:06 pmRNSHalf-year Report
2nd Sep 20201:00 pmRNSDirector/PDMR Shareholding
27th Aug 20207:00 amRNSHalf-year Report
6th Jul 20207:00 amRNSTrading Update
25th Jun 202012:08 pmRNSSecond Price Monitoring Extn
25th Jun 202012:03 pmRNSPrice Monitoring Extension
16th Jun 20203:59 pmRNSHolding(s) in Company
18th May 20204:35 pmRNSPrice Monitoring Extension
15th May 20209:30 amRNSChange of Company Secretary
13th May 20209:30 amRNSResult of AGM
12th May 202012:00 pmRNSAGM Statement
5th May 202010:00 amRNSDisclosure of rights attached to equity shares
9th Apr 20204:30 pmRNSNotice of AGM
6th Apr 20207:00 amRNSAnnual Report 2019
30th Mar 20207:00 amRNSCOVID-19 Trading Update
18th Mar 20204:43 pmRNSSecond Price Monitoring Extn
18th Mar 20204:39 pmRNSPrice Monitoring Extension
13th Mar 20204:42 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.